TNBTD
SLS icon

Trustmark National Bank Trust Department’s SELLAS Life Sciences SLS Stock Holding History

Trustmark National Bank Trust Department’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,000
Closed -$90.5K – 282
2025
Q4 		$90.5K Sell
24,000
-12,511
-34% -$24.3K 0.01% 279
2025
Q3 		$58.8K Buy
+36,511
New +$65K ﹤0.01% 277

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Trustmark National Bank Trust Department's SLS Position: Q1 2026 in Review

Trustmark National Bank Trust Department sold out of SELLAS Life Sciences (SLS) in Q1 2026, closing a stake of 24,000 shares — an estimated $90.5K sold.

Trustmark National Bank Trust Department first reported a position in SLS in Q3 2025 and held it in 2 quarters. The position peaked at $90.5K in Q4 2025. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Trustmark National Bank Trust Department reported no remaining SELLAS Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 24,000 SELLAS Life Sciences shares in Q1 2026, an estimated $90.5K.
  • Trustmark National Bank Trust Department first reported a position in SELLAS Life Sciences in Q3 2025 and held it in 2 quarters.
  • Trustmark National Bank Trust Department's SELLAS Life Sciences position peaked at $90.5K in Q4 2025.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Trustmark National Bank Trust Department's 13F filing for Q1 2026, filed 14 May 2026.